title: Thrombin generation in two FXI-deficient patients treated with Hemoleven®.
authors.affiliation: Service d'Hématologie-Biologique, Hôpital Beaujon, HUPNVS, AP-HP, Clichy, France; Centre de traitement de l'Hémophilie, Hôpital Mignot, Le Chesnay, France.
authors.forename: E
authors.initials: E
authors.lastname: de Raucourt
authors.forename: V
authors.initials: V
authors.lastname: Ollivier
authors.forename: D
authors.initials: D
authors.lastname: Faille
authors.forename: B
authors.initials: B
authors.lastname: Bastenaire
authors.forename: N
authors.initials: N
authors.lastname: Ajzenberg
mesh_terms: D000369:Aged, 80 and over; D005172:Factor XI / Q000008:administration & dosage / Q000627:therapeutic use*; D005173:Factor XI Deficiency / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D008297:Male; D013917:Thrombin / Q000378:metabolism*; D016896:Treatment Outcome
chemical_list: D005172:Factor XI; D013917:Thrombin